Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3417578
Max Phase: Preclinical
Molecular Formula: C48H60N4O10S
Molecular Weight: 885.09
Molecule Type: Small molecule
Associated Items:
ID: ALA3417578
Max Phase: Preclinical
Molecular Formula: C48H60N4O10S
Molecular Weight: 885.09
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1(C)CC[C@]2(C(=O)N3CCC[C@H]3C(=O)OCCCCOc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)CC[C@]3(C)[C@H](C(=O)C=C4[C@@]5(C)C=C(C#N)C(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1
Standard InChI: InChI=1S/C48H60N4O10S/c1-43(2)19-21-48(22-20-47(7)37(32(48)28-43)34(53)26-36-45(5)27-30(29-49)38(54)44(3,4)35(45)17-18-46(36,47)6)42(56)51-23-13-16-33(51)41(55)61-25-12-11-24-60-39-40(52(57)62-50-39)63(58,59)31-14-9-8-10-15-31/h8-10,14-15,26-27,32-33,35,37H,11-13,16-25,28H2,1-7H3/t32-,33-,35-,37-,45-,46+,47+,48-/m0/s1
Standard InChI Key: DZCJDMXQHZWSED-YDOUTGMUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 885.09 | Molecular Weight (Monoisotopic): 884.4030 | AlogP: 7.05 | #Rotatable Bonds: 10 |
Polar Surface Area: 200.88 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 0 |
#RO5 Violations: 3 | HBA (Lipinski): 14 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: | CX Basic pKa: 0.83 | CX LogP: 7.51 | CX LogD: 7.51 |
Aromatic Rings: 2 | Heavy Atoms: 63 | QED Weighted: 0.13 | Np Likeness Score: 0.67 |
1. Ai Y, Kang F, Huang Z, Xue X, Lai Y, Peng S, Tian J, Zhang Y.. (2015) Synthesis of CDDO-amino acid-nitric oxide donor trihybrids as potential antitumor agents against both drug-sensitive and drug-resistant colon cancer., 58 (5): [PMID:25675144] [10.1021/jm5019302] |
Source(1):